Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Urinary Dysfunction in Myasthenia Gravis: Clinical Burden and Association with MG-ADL

Author:Shihada, Kamel   Gorenshtein, Alon   Wolfe, Gil   Shelly, Shahar   

Session Name:P4: Neuromuscular and Clinical Neurophysiology (EMG): Neuromuscular Junction Disorders  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P4.012  

Author Institution:Bar-Ilan University, Nof Hgalil, Israel  Rambam Medical Center, Haifa, Israel  Univ. At Buffalo, SUNY, Buffalo, NY  

Neurological Manifestations of IgG4-related disease: To Wait Or To Mitigate?

Author:Marsia, Shayan   Iqbal, Minahil   Barakat, Farah   Shahid, Sufyan   Barakat, Ayla   Lannen, Nicholas   

Session Name:P4: Autoimmune Neurology: Inflammatory NOS 2  

Topic:Autoimmune Neurology  

Program Number:P4.012  

Author Institution:Corewell Health/Michigan State University, Grand Rapids, MI  Allama Iqbal Medical College, Lahore, Pakistan  Al Faisal Medical University, Riyadh, Saudi Arabia  Khawaja Muhammad Safdar Medical College, Sialkot, Pakistan  Corewell Health/Michigan State University, Belmont, MI  

Bilateral Optic Perineuritis: A Rare Manifestation of Giant Cell Arteritis- Case Report and Literature Review

Author:Aldriweesh, Mohammed   Madkhali, Jnadi   Aba Alkhail, Ahmed   Almalik, Yaser   

Session Name:P4: Neuro-ophthalmology/Neuro-otology: Vascular Neuro-ophthalmic Diseases  

Topic:Neuro-ophthalmology/Neuro-otology  

Program Number:P4.012  

Author Institution:King Abdulaziz Medical City, Riyadh, Saudi Arabia  King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia  

High-dose Onabotulinumtoxin Type A for Management of Severe Multiple Sclerosis-related Bladder Symptoms

Author:Cheung, Richard   Lindner, Aubrie   Palencia, Peter   Zabad, Rana   Feloney, Michael   

Session Name:P4: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 4  

Topic:Multiple Sclerosis  

Program Number:P4.012  

Author Institution:Creighton University School of Medicine, Omaha, NE  University of Nebraska Medical Center, NE  Creighton University School of Medicine, NE  University of Nebraska Medical Center, Omaha, NE  

The Evolution of Randomized Clinical Trial Designs to Assess Therapeutics in Alzheimer Disease

Author:Arfaie, Saman   Aumont, Etienne   Therriault, Joseph   Kwan, Angela   Carello-Collar, Giovanna   Hall, Brandon   Ferrari-Souza, João-Pedro   Woo, Marcel   Macedo, Arthur   Tissot, Cécile   Trudel, Lydia   Rahmouni, Nesrine   Servaes, Stijn   Vitali, Paolo   Soucy, Jean-Paul   Pascoal, Tharick   Zimmer, Eduardo   Gauthier, Serge   Rosa Neto, Pedro   

Session Name:P4: Aging, Dementia, and Behavioral Neurology: Alzheimer's Disease: Beyond Anti-amyloid Therapeutics 2  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P4.012  

Author Institution:McGill University Research Centre for Studies in Aging, Montréal, QC, Canada  McGill University Research Centre for Studies in Aging, QC, Canada  McGill University Research Centre for Studies in Aging, Ottawa, ON, Canada  Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, , Brazil  6Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Hamburg, Germany  Lawrence Berkeley National Laboratory, University of California, Berkeley, CA  McGill University Research Centre for Studies in Aging, Montreal, QC, Canada  University of Pittsburgh, Pittsburgh, PA  Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil, PORTO ALEGRE, Brazil  Douglas Hospital, Verdun, QC, Canada